# EDGAR Filing Document

**Accession Number:** 0001023313
**File Stem:** 0001193125-25-274219
**Filing Date:** 2025-11
**Character Count:** 152376
**Document Hash:** 215027b8d03fbce84c683c47365d4a76
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-274219.hdr.sgml**: 20251110

**ACCESSION NUMBER**: 0001193125-25-274219

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 90

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251110

**DATE AS OF CHANGE**: 20251110

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FORRESTER RESEARCH, INC.
- **CENTRAL INDEX KEY:** 0001023313
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-ENGINEERING, ACCOUNTING, RESEARCH, MANAGEMENT [8700]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 042797789
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21433
- **FILM NUMBER:** 251466227

**BUSINESS ADDRESS:**
- **STREET 1:** 60 ACORN PARK DRIVE
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02140
- **BUSINESS PHONE:** 6176136000

**MAIL ADDRESS:**
- **STREET 1:** 60 ACORN PARK DRIVE
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02140

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FORRESTER RESEARCH INC
- **DATE OF NAME CHANGE:** 19960919

?xml version='1.0' encoding='ASCII'? 10-Q

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

------

**FORM** 10-Q

------

**(MARK ONE)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.** 

**FOR THE QUARTERLY PERIOD ENDED** **September 30,** 2025

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.**

**COMMISSION FILE NUMBER:** 000-21433

------

FORRESTER RESEARCH, INC.

**(Exact name of registrant as specified in its charter)**

------

---

| | |
|:---|:---|
| Delaware | 04-2797789 |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification Number)** |
| 60 Acorn Park Drive<br>Cambridge**,** Massachusetts | 02140<br>**(Zip Code)** |
| **(Address of principal executive offices)** |  |

---

**(**617**)** 613-6000

**(Registrant's telephone number, including area code)**

------

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of Each Exchange on Which Registered** |
| Common Stock, $.01 Par Value | FORR | Nasdaq **Global Select Market** |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 3, 2025, 19,003,000 shares of the registrant's common stock were outstanding.

------

**FORRESTER RESEARCH, INC.**

**INDEX TO FORM 10-Q**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **PART I** | **FINANCIAL INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;Item 1. | [<u>Financial Statements (Unaudited)</u>](#item_1_financial_statements) | 3 |
|  | [<u>Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024</u>](#consolidated_balance_sheets) | 3 |
|  | [<u>Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024</u>](#consolidated_statements_income) | 4 |
|  | [<u>Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2025 and 2024</u>](#consolidated_statements_comprehensive_in) | 5 |
|  | [<u>Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024</u>](#consolidated_statements_cash_flows) | 6 |
|  | [<u>Notes to Consolidated Financial Statements</u>](#notes_to_consolidated_financial_statemen) | 7 |
| &nbsp;&nbsp;&nbsp;Item 2. | [<u>Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2_managements_discussion_analysis_f) | 24 |
| &nbsp;&nbsp;&nbsp;Item 3. | [<u>Quantitative and Qualitative Disclosures About Market Risk</u>](#item_3_quantitative_qualitative_disclosu) | 35 |
| &nbsp;&nbsp;&nbsp;Item 4. | [<u>Controls and Procedures</u>](#item_4_controls_procedures) | 35 |
| **PART II** | **OTHER INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;Item 1. | [<u>Legal Proceedings</u>](#part_ii_item_1_legal_proceedings) | 36 |
| &nbsp;&nbsp;&nbsp;Item 1A. | [<u>Risk Factors</u>](#part_ii_item_1a_risk_factors) | 36 |
| &nbsp;&nbsp;&nbsp;Item 2. | [<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#part_ii_item_2_unregestered_sales_of_equ) | 36 |
| &nbsp;&nbsp;&nbsp;Item 3. | [<u>Defaults Upon Senior Securities</u>](#part_ii_item_3_defaults_upon_senior_secu) | 36 |
| &nbsp;&nbsp;&nbsp;Item 4. | [<u>Mine Safety Disclosures</u>](#part_ii_item_4_mine_safety_disclosures) | 36 |
| &nbsp;&nbsp;&nbsp;Item 5. | [<u>Other Information</u>](#part_ii_item_5_other_information) | 37 |
| &nbsp;&nbsp;&nbsp;Item 6. | [<u>Exhibits</u>](#part_ii_item_6_exhibits) | 37 |
| [<u>SIGNATURES</u>](#signatures) | [<u>SIGNATURES</u>](#signatures) | 38 |

---

------

**PART I.**

**ITEM 1. FINANCIAL STATEMENTS**

**FORRESTER RESEARCH, INC.**

**CONSOLIDATED BALANCE SHEETS**

**(In thousands, except per share data, unaudited)**

---

| | | |
|:---|:---|:---|
|  | **September 30,** | **December 31,** |
|  | **2025** | **2024** |
| **ASSETS** |  |  |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $65121 | $56087 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketable investments | 66831 | 48582 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance for expected credit losses of $310 and $434 as<br> of September 30, 2025 and December 31, 2024, respectively | 33588 | 55490 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred commissions | 16436 | 22942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 11662 | 18263 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 193638 | 201364 |
| Property and equipment, net | 9702 | 11699 |
| Operating lease right-of-use assets | 31885 | 27049 |
| Goodwill | 147195 | 227959 |
| Intangible assets, net | 20824 | 27475 |
| Other assets | 10937 | 8316 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $414181 | $503862 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $1824 | $965 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 39034 | 57602 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 141246 | 145404 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 182104 | 203971 |
| Long-term debt | 35000 | 35000 |
| Non-current operating lease liabilities | 31792 | 24809 |
| Other non-current liabilities | 7613 | 10545 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 256509 | 274325 |
| Commitments and contingencies (Note 17) |  |  |
| Stockholders' Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.01 par value |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized - 500 shares; issued and outstanding - none |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized - 125,000 shares |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issued - 25,511 and 25,119 shares as of September 30, 2025 and December 31, 2024,<br> respectively |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Outstanding - 18,989 and 18,838 shares as of September 30, 2025 and<br> December 31, 2024, respectively | 255 | 251 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 301755 | 292217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 86449 | 171934 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock - 6,522 and 6,282 shares as of September 30, 2025 and December 31, 2024, respectively | (229615) | (227119) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (1172) | (7746) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 157672 | 229537 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $414181 | $503862 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

**FORRESTER RESEARCH, INC.**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

**(In thousands, except per share data, unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research | $72652 | $77070 | $218992 | $237314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting | 21475 | 23369 | 66404 | 71321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Events | 168 | 2088 | 10434 | 15794 |
| Total revenues | 94295 | 102527 | 295830 | 324429 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of services and fulfillment | 37711 | 42174 | 126966 | 138028 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and marketing | 36011 | 38273 | 109031 | 117948 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 12478 | 15738 | 38907 | 44234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 1532 | 1957 | 4671 | 6079 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 2217 | 2404 | 6651 | 7431 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment |  |  | 83895 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs | (111) | 937 | 1887 | 7643 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from sale of divested operation |  | 1775 |  | 1775 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 89838 | 103258 | 372008 | 323138 |
| Income (loss) from operations | 4457 | (731) | (76178) | 1291 |
| Interest expense | (684) | (770) | (2026) | (2295) |
| Loss on investments, net |  |  | (114) |  |
| Credit loss expense on note receivable | (6400) |  | (7310) |  |
| Other income, net | 938 | 427 | 2753 | 2716 |
| Income (loss) before income taxes | (1689) | (1074) | (82875) | 1712 |
| Income tax expense | 437 | 4724 | 2610 | 7891 |
| Net loss | $(2126) | $(5798) | $(85485) | $(6179) |
| Basic loss per common share | $(0.11) | $(0.30) | $(4.49) | $(0.32) |
| Diluted loss per common share | $(0.11) | $(0.30) | $(4.49) | $(0.32) |
| Basic weighted average common shares outstanding | 19113 | 19065 | 19022 | 19147 |
| Diluted weighted average common shares outstanding | 19113 | 19065 | 19022 | 19147 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

**FORRESTER RESEARCH, INC.**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

**(In thousands, unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net loss | $(2126) | $(5798) | $(85485) | $(6179) |
| Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation | (893) | 4142 | 6545 | 1963 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in market value of investments | 21 | 107 | 29 | 131 |
| Other comprehensive income (loss) | (872) | 4249 | 6574 | 2094 |
| Comprehensive loss | $(2998) | $(1549) | $(78911) | $(4085) |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

**FORRESTER RESEARCH, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(In thousands, unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(85485) | $(6179) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 4671 | 6079 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of property and equipment | 67 | 991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 6651 | 7431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (3537) | (359) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 9831 | 11202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit losses on note receivable | 7310 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment | 83895 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reduction in the carrying amount of operating lease right-of-use assets | 5419 | 10728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from sale of divested operation |  | 1775 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 941 | 1172 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 21996 | 16852 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred commissions | 6505 | 6813 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (3995) | (6435) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 845 | (219) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | (15363) | (36455) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (6924) | (4479) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (8534) | (10948) |
| Net cash provided by (used in) operating activities | 24293 | (2031) |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (1923) | (2743) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of marketable investments | (32283) | (55800) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from maturities of marketable investments | 12050 | 49735 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of marketable investments | 4813 | 7650 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of divested operation |  | 6000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investing activity | 1638 | (68) |
| Net cash provided by (used in) investing activities | (15705) | 4774 |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchases of common stock | (2407) | (12984) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock under employee equity incentive plans | 1264 | 2426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net share settlements of stock-based compensation awards | (1231) | (2490) |
| Net cash used in financing activities | (2374) | (13048) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 2973 | 259 |
| Net change in cash, cash equivalents and restricted cash | 9187 | (10046) |
| Cash, cash equivalents and restricted cash, beginning of period | 58186 | 75042 |
| Cash, cash equivalents and restricted cash, end of period | $67373 | $64996 |
| Supplemental disclosure of cash flow information: |  |  |
| Cash paid for interest | $1694 | $1762 |
| Cash paid for income taxes | $6455 | $8542 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

**FORRESTER RESEARCH, INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**Note 1 — Interim Consolidated Financial Statements**

*Basis of Presentation*

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for reporting on Form 10-Q. Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. The year-end balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. It is recommended that these financial statements be read in conjunction with the consolidated financial statements and related notes that appear in the Forrester Research, Inc. ("Forrester") Annual Report on Form 10-K for the year ended December 31, 2024. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the financial position, results of operations, comprehensive loss, and cash flows as of the dates and for the periods presented have been included. The results of operations for the three and nine months ended September 30, 2025 may not be indicative of the results for the year ending December 31, 2025, or any other period.

*Presentation of Restricted Cash*

The following table summarizes the end-of-period cash and cash equivalents from the Company's Consolidated Balance Sheets and the total cash, cash equivalents and restricted cash as presented on the accompanying Consolidated Statements of Cash Flows (in thousands).

---

| | | |
|:---|:---|:---|
|  | **As of September 30,** | **As of September 30,** |
|  | **2025** | **2024** |
| Cash and cash equivalents shown in balance sheets | $65121 | $62754 |
| Restricted cash classified in other assets (1): | 2252 | 2242 |
| Cash, cash equivalents and restricted cash shown in statement of cash flows | $67373 | $64996 |

---

(1)Restricted cash consists of collateral required for leased office space. The short-term or long-term classification regarding the collateral for the leased office space is determined in accordance with the expiration of the underlying leases.

*Adoption of New Accounting Pronouncements*

There were no recent accounting pronouncements adopted by the Company during the nine months ended September 30, 2025.

*Recent Accounting Pronouncements*

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - *Improvements to Income Tax Disclosures*. The new standard enhances income tax disclosure requirements by requiring specified categories and greater disaggregation within the rate reconciliation table, disclosure of income taxes paid by jurisdiction, and providing clarification on uncertain tax positions and related financial statement impacts. The new standard will be effective for annual filings for the Company beginning in 2025, and quarterly filings thereafter. The adoption of the standard on a retrospective basis will result in additional disclosures in the Company's income tax footnote.

In November 2024, the FASB issued ASU No. 2024-03, *Disaggregation of Income Statement Expenses*. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The new standard will be effective for the Company on January 1, 2027, with early adoption permitted. The Company anticipates adopting this standard on January 1, 2027, which will result in additional disclosures of expenses in the footnotes to its financial statements.

------

**Note 2 — Divestiture**

In August 2024, the Company completed the sale of a non-core product line, FeedbackNow, for approximately $17.6 million. The Company received $6.0 million in cash from the sale, along with a note receivable of $9.0 million, and a non-marketable equity investment in the acquirer valued at $2.6 million, which is accounted for under the cost method. The Company recorded a pre-tax loss of $1.8 million on the sale of FeedbackNow, which is included in loss from sale of divested operation in the Consolidated Statements of Operations for the year ended December 31, 2024. The FeedbackNow product line was included in the Company's Research segment. The principal components of the assets divested included goodwill, property and equipment, and accounts receivable, with carrying amounts of $14.8 million, $2.2 million, and $2.4 million, respectively, while the liabilities transferred with the sale primarily consisted of deferred revenue with a carrying amount of $1.8 million.

The repayment terms of the note were modified during the first quarter of 2025 resulting in $1.5 million plus all accrued interest being due in December 2025, and the remainder due in the second quarter of 2026. The Company measures the note receivable on an amortized cost basis and records the estimate of any expected credit losses on the note receivable as an allowance for credit losses. In conjunction with the modification of the repayment terms of the note, the Company updated its analysis of the current expected credit loss for the note. As a result, during the three months ended March 31, 2025, the Company recorded a $0.9 million allowance for credit losses.

As a result of a change in the borrower's expected ability to make the scheduled payments on the note,during the three months ended September 30, 2025, the Company's assessment of default risk on the note increased. Accordingly, the Company updated its analysis of the current expected credit loss for the note. As a result, the Company recorded an additional $6.4 million allowance for credit losses during the three months ended September 30, 2025. If any amount of the note is determined by the Company to be uncollectible due to the borrower's failure to meet repayment terms or due to the borrower's deteriorating financial condition, the write-off amount, reduced by any previously recorded allowances, would also be recorded as a credit loss expense. As of September 30, 2025, the balance of the note receivable, inclusive of capitalized interest at the stated rate of 8%, is $9.9 million. The carrying value of the note, net of the cumulative allowance for credit losses, is $2.6 million and is recorded within other assets in the Consolidated Balance Sheets. The allowance for credit losses is reported as a valuation account on the balance sheet that is deducted from the note receivable's amortized cost basis and is included in credit loss expense on note receivable in the Consolidated Statement of Operations. During the year ended December 31, 2024, no material allowance or write-off amounts were recorded.

In addition, given that collection of interest on the loan is less than probable, interest income recognition was suspended during the three months ended September 30, 2025. As such, interest income will only be recognized to the extent that cash is received. In the future, the accrual of interest income will be restored only when the borrower is contractually current or the collection of future payments is reasonably assured. As of September 30, 2025, the note receivable remains in nonaccrual status. The amount of interest income recognized during the three and nine months ended September 30, 2025, was $0.1 million and $0.5 million, respectively.

**Note 3 — Marketable Investments**

The following table summarizes the Company's marketable investments (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  |  | **Gross** | **Gross** |  |
|  | **Amortized** | **Unrealized** | **Unrealized** | **Market** |
|  | **Cost** | **Gains** | **Losses** | **Value** |
| Corporate obligations | $18229 | $81 | $(1) | $18309 |
| Federal agency obligations | 1492 |  | (3) | 1489 |
| Money market funds | 47033 |  |  | 47033 |
| Total | $66754 | $81 | $(4) | $66831 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  |  | **Gross** | **Gross** |  |
|  | **Amortized** | **Unrealized** | **Unrealized** | **Market** |
|  | **Cost** | **Gains** | **Losses** | **Value** |
| Corporate obligations | $12140 | $46 | $(6) | $12180 |
| Money market funds | 36402 |  |  | 36402 |
| Total | $48542 | $46 | $(6) | $48582 |

---

------

Realized gains and losses on investments are included in earnings and are determined using the specific identification method. Sales of marketable investments during 2025 and 2024 primarily represent redemptions from non-U.S. based money market funds, and realized gains or losses on sales of marketable investments were immaterial during the three and nine months ended September 30, 2025 and 2024.

The following table summarizes the maturity periods of the marketable investments in the Company's portfolio as of September 30, 2025 (in thousands).

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **FY 2025** | **FY 2026** | **FY 2027** | **FY 2028** | **Total** |
| Corporate obligations | $1620 | $8037 | $4798 | $3854 | $18309 |
| Federal agency obligations | 992 |  | 497 |  | 1489 |
| Money market funds | 47033 |  |  |  | 47033 |
| Total | $49645 | $8037 | $5295 | $3854 | $66831 |

---

The following table shows the gross unrealized losses and market value of the Company's available-for-sale securities with unrealized losses that are not deemed to be other-than-temporary, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or Greater** | **12 Months or Greater** |
|  | **Market** | **Unrealized** | **Market** | **Unrealized** |
|  | **Value** | **Losses** | **Value** | **Losses** |
| Corporate obligations | $1119 | $1 | $— | $— |
| Federal agency obligations | 497 | 3 |  |  |
| Total | $1616 | $4 | $— | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or Greater** | **12 Months or Greater** |
|  | **Market** | **Unrealized** | **Market** | **Unrealized** |
|  | **Value** | **Losses** | **Value** | **Losses** |
| Corporate obligations | $803 | $4 | $997 | $2 |
| Total | $803 | $4 | $997 | $2 |

---

**Note 4 — Goodwill and Other Intangible Assets** 

*Goodwill*

Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair values of the tangible and identifiable intangible net assets acquired. Goodwill is not amortized; however, it is required to be tested for impairment annually, which requires assessment of the potential impairment at the reporting unit level. Reporting units are determined based on the components of the Company's operating segments that constitute a business for which discrete financial information is available and for which operating results are regularly reviewed by segment management. Testing for impairment is also required on an interim basis if an event or circumstance indicates it is more likely than not an impairment loss has been incurred.

The income approach was based upon projected future cash flows that were discounted to present value. The key underlying assumptions included forecasted revenues, operating expenses, terminal rate, as well as an applicable discount rate for each reporting unit. The key assumptions in the market approach were the earnings multiple and market participant acquisition premium. Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions that have been deemed reasonable by the Company. Changes in the estimates or assumptions used in the quantitative impairment test could materially affect the determination of fair value of the Company's reporting units and the associated goodwill impairment assessment.

------

Potential events and circumstances that could have an adverse impact on the Company's estimates and assumptions include, but are not limited to, lower than expected bookings growth, increases in costs, and other macroeconomic factors.

The Company will complete its annual goodwill impairment test as of November 30, 2025. In addition, throughout the remainder of 2025, the Company will continue to monitor relevant facts and circumstances, including future changes in its stock price, to determine if another interim impairment test is required. The Company may be required to record additional goodwill impairment charges. Management concluded that a triggering event did not occur during the three months ended June 30, 2025 and September 30, 2025 and as such, a quantitative impairment test of goodwill was not required during either period. While management cannot predict if or when additional goodwill impairments may occur, future goodwill impairments could have material adverse effects on the Company's results of operations and financial condition.

Goodwill of $8.3 million is allocated to the Company's Consulting reporting unit, which had a negative carrying value as of March 31, 2025, the date of the last impairment test.

The change in the carrying amount of goodwill for the nine months ended September 30, 2025 is summarized as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Total** |
| Balance at December 31, 2024 | $219814 | $8145 | $227959 |
| Impairment | (83895) |  | (83895) |
| Translation adjustments | 2980 | 151 | 3131 |
| Balance at September 30, 2025 | $138899 | $8296 | $147195 |

---

The Company reviews long-lived assets, including property and equipment, operating lease right-of-use assets, and finite-lived intangible assets, for impairment when an event occurs that may indicate potential impairment. In connection with the identified triggering event as of March 31, 2025, the Company performed, prior to the goodwill impairment test, a quantitative assessment of its long-lived assets by comparing undiscounted future cash flows to the net carrying value of the underlying assets, and concluded that its long-lived assets were not impaired. However, if future events occur or if business conditions deteriorate, the Company may be required to record an impairment loss, and or accelerate the amortization of finite-lived intangible assets in the future, which could be material to its results of operations and financial condition.

*Finite-Lived Intangible Assets*

The carrying values of finite-lived intangible assets are as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|  | **Gross** |  | **Net** |
|  | **Carrying** | **Accumulated** | **Carrying** |
|  | **Amount** | **Amortization** | **Amount** |
| Amortizable intangible assets: |  |  |  |
| &nbsp;&nbsp;Customer relationships | $77000 | $56189 | $20811 |
| &nbsp;&nbsp;Technology | 13000 | 12987 | 13 |
| Total | $90000 | $69176 | $20824 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Gross** |  | **Net** |
|  | **Carrying** | **Accumulated** | **Carrying** |
|  | **Amount** | **Amortization** | **Amount** |
| Amortizable intangible assets: |  |  |  |
| &nbsp;&nbsp;Customer relationships | $77000 | $49946 | $27054 |
| &nbsp;&nbsp;Technology | 13000 | 12978 | 22 |
| &nbsp;&nbsp;Trademarks | 12000 | 11601 | 399 |
| Total | $102000 | $74525 | $27475 |

---

Estimated intangible asset amortization expense for each of the four succeeding years is as follows (in thousands):

---

| | |
|:---|:---|
| 2025 (remainder) | $2095 |
| 2026 | 8324 |
| 2027 | 8324 |
| 2028 | 2081 |
| Total | $20824 |

---

------

**Note 5 — Debt**

The Company has a credit facility that provides up to $150.0 million of revolving credit commitments and matures in December of 2026. The credit facility includes an expansion feature that permits the Company to increase the revolving credit commitments in an aggregate principal amount up to $50.0 million, subject to approval by the administrative agent and certain customary terms and conditions.

The credit facility contains certain customary restrictive loan covenants, including among others, financial covenants that apply a maximum leverage ratio, minimum interest coverage ratio, and maximum annual capital expenditures. The negative covenants limit, subject to various exceptions, the Company's ability to incur additional indebtedness, create liens on assets, merge, consolidate, liquidate or dissolve any part of the Company, sell assets, change fiscal year, or enter into certain transactions with affiliates and subsidiaries. The Company was in full compliance with the covenants as of September 30, 2025.

The Company may voluntarily prepay revolving loans under the credit facility at any time and from time to time, without premium or penalty. No interim amortization payments are required to be made under the credit facility.

Up to $5.0 million of the credit facility is available for the issuance of letters of credit, and any drawings under the letters of credit must be reimbursed within one business day. As of September 30, 2025, $0.7 million in letters of credit were issued under the credit facility.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*Outstanding Borrowings*

The following table summarizes the Company's total outstanding borrowings as of the dates indicated (in thousands):

---

| | | |
|:---|:---|:---|
| **Description:** | **September 30, 2025** | **December 31, 2024** |
| Credit facility | $35000 | $35000 |

---

The contractual annualized interest rate as of September 30, 2025 was 5.51%.

The Company had $114.3 million of available borrowing capacity on the credit facility (not including the expansion feature) as of September 30, 2025. The weighted average annual effective interest rate for both the three and nine months ended September 30, 2025, was 5.68%.

All obligations under the credit facility are unconditionally guaranteed by each of the Company's existing and future, direct and indirect, material wholly-owned domestic subsidiaries, other than certain excluded subsidiaries, and are collateralized by a first priority lien on substantially all tangible and intangible assets, including intellectual property, and all of the capital stock of the Company's subsidiaries (limited to 65% of the voting equity of certain subsidiaries).

**Note 6 — Leases**

All of the Company's leases are operating leases, the majority of which are for office space. Operating lease right-of-use ("ROU") assets and non-current operating lease liabilities are included as individual line items in the Consolidated Balance Sheets, while short-term operating lease liabilities are recorded within accrued expenses and other current liabilities. Leases with an initial term of twelve months or less are not recorded in the Consolidated Balance Sheets and are not material.

The components of lease expense were as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended September 30,** | **For the Three Months Ended September 30,** |
|  | **2025** | **2024** |
| Operating lease cost | $1776 | $2902 |
| Short-term lease cost | 444 | 291 |
| Variable lease cost | 880 | 1311 |
| Sublease income |  | (133) |
| Total lease cost | $3100 | $4371 |

---

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended September 30,** | **For the Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Operating lease cost | $6096 | $8893 |
| Short-term lease cost | 1259 | 737 |
| Variable lease cost | 3203 | 3579 |
| Sublease income |  | (394) |
| Total lease cost | $10558 | $12815 |

---

------

Additional lease information is summarized in the following table (in thousands, except lease term and discount rate):

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended September 30,** | **For the Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Cash paid for amounts included in the measurement of operating<br> lease liabilities | $8534 | $10948 |
| Operating lease ROU assets obtained in exchange for lease<br> obligations | $9899 | $408 |
| Weighted-average remaining lease term - operating leases (years) | 9.0 | 3.8 |
| Weighted-average discount rate - operating leases | 5.1% | 4.2% |

---

Future minimum lease payments under non-cancelable leases as of September 30, 2025 are as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **Operating Lease** | **Tenant Improvement** | **Net Undiscounted** |
|  | **Payments** | **Allowance** | **Cash Flows** |
| 2025 (remainder) | $2844 | $(342) | $2502 |
| 2026 | 7590 | (16809) | (9219) |
| 2027 | 8273 |  | 8273 |
| 2028 | 6547 |  | 6547 |
| 2029 | 6623 |  | 6623 |
| Thereafter | 44223 |  | 44223 |
| Total | 76100 | (17151) | 58949 |
| Less imputed interest |  |  | (19661) |
| Present value of lease liabilities |  |  | $39288 |

---

Lease balances as of September 30, 2025 are as follows (in thousands):

---

| | |
|:---|:---|
| Operating lease ROU assets | $31885 |
| Short-term operating lease liabilities (1) | $7496 |
| Non-current operating lease liabilities | 31792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating lease liabilities | $39288 |

---

(1)Included in accrued expenses and other current liabilities in the Consolidated Balance Sheets.

The Company's leases do not contain residual value guarantees, material restrictions, or covenants.

On April 11, 2025, the Company entered into a third amendment of its lease, and a new lease, for its principal headquarters located in Cambridge, Massachusetts. The effect of these agreements was to early terminate the original lease with respect to the first, second and third floors of the facility on or before May 31, 2026, while also extending the lease term with respect to the fourth, fifth and six floors of the facility through June 30, 2039. Variable lease costs in the new lease consist of operating costs, taxes and parking. The Company has the right to extend the new lease term for two terms of ten years each. The new lease does not contain residual value guarantees, material restrictions or covenants.

During the nine months ended September 30, 2024, the Company recorded $3.6 million of ROU asset impairments and $1.0 million of leasehold improvements impairments related to closing the 10th and 11th floors of its offices located in San Francisco, California. The impairments are included in restructuring costs in the Consolidated Statements of Operations. As a result of the impairments, the ROU assets were required to be recorded at their estimated fair values as Level 3 non-financial assets. The fair values of the asset groups were determined using a discounted cash flow model, which required the use of estimates, including projected cash flows for the related assets, the selection of a discount rate used in the model, and regional real estate industry data.

------

**Note 7 – Revenue and Related Matters**

*Disaggregated Revenue*

The Company disaggregates revenue as set forth in the following tables (in thousands):

<u>Revenue by Geography</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended September 30,** | **For the Three Months Ended September 30,** | **For the Nine Months Ended September 30,** | **For the Nine Months Ended September 30,** |
| **Revenues: (1)** | **2025** | **2024** | **2025** | **2024** |
| North America | $73648 | $81932 | $237151 | $260611 |
| Europe | 13046 | 13274 | 37248 | 41715 |
| Asia Pacific | 5840 | 5058 | 16371 | 15259 |
| Other | 1761 | 2263 | 5060 | 6844 |
| Total | $94295 | $102527 | $295830 | $324429 |

---

(1)Revenue location is determined based on where the products and services are consumed.

*Contract Assets and Contract Liabilities*

<u>Accounts Receivable</u>

Accounts receivable includes amounts billed and currently due from customers. Since the only condition for payment of the Company's invoices is the passage of time, a receivable is recorded on the date an invoice is issued. Also included in accounts receivable are unbilled amounts resulting from revenue exceeding the amount billed to the customer, where the right to payment is unconditional. If the right to payment for services performed was conditional on something other than the passage of time, the unbilled amount would be recorded as a separate contract asset. There were no contract assets as of September 30, 2025 or December 31, 2024.

The majority of the Company's contracts are non-cancelable. However, for contracts that are cancelable by the customer, the Company does not record a receivable when it issues an invoice. The Company records accounts receivable on these contracts only up to the amount of revenue earned but not yet collected.

In addition, since the majority of the Company's contracts are invoiced for annual periods, and payment is expected within one year from the transfer of products and services, the Company does not adjust its receivables or transaction prices for the effects of a significant financing component.

<u>Deferred Revenue</u>

The Company refers to contract liabilities as deferred revenue in the Consolidated Balance Sheets. Payment terms in the Company's customer contracts vary, but generally require payment in advance of fully satisfying the performance obligation(s). Deferred revenue consists of billings in excess of revenue recognized. Similar to accounts receivable, the Company does not record deferred revenue for unpaid invoices issued on a cancelable contract.

During the three months ended September 30, 2025 and 2024, the Company recognized $20.6 million and $22.7 million, respectively, related to its deferred revenue balance at the beginning of each such period. During the nine months ended September 30, 2025 and 2024, the Company recognized $127.7 million and $133.2 million of revenue, respectively, related to its deferred revenue balance at January 1 of each such period.

Approximately $334.5 million of revenue is expected to be recognized during the next 36 months from remaining performance obligations as of September 30, 2025.

*Reserves for Credit Losses on Accounts Receivable*

The allowance for expected credit losses on accounts receivable for the nine months ended September 30, 2025 is summarized as follows (in thousands):

---

| | |
|:---|:---|
|  | **Total<br>Allowance** |
| Balance at December 31, 2024 | $434 |
| Provision for expected credit losses | 10 |
| Write-offs | (134) |
| Balance at September 30, 2025 | $310 |

---

------

When evaluating the adequacy of the allowance for expected credit losses, the Company makes judgments regarding the collectability of accounts receivable based, in part, on the Company's historical loss rate experience, customer concentrations, management's expectations of future losses as informed by current economic conditions, and changes in customer payment terms. If the expected financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. If the expected financial condition of the Company's customers were to improve, the allowances may be reduced accordingly.

*Cost to Obtain Contracts*

The Company capitalizes commissions paid to sales representatives and related fringe benefits costs that are incremental to obtaining customer contracts. These costs are included in deferred commissions in the Consolidated Balance Sheets. The Company accounts for these costs at a portfolio level as the Company's contracts are similar in nature and the amortization model used closely matches the amortization expense that would be recognized on a contract-by-contract basis. Costs to obtain a contract are amortized to earnings over the initial contract term, which is the same period the related revenue is recognized. Amortization expense related to deferred commissions for both the three months ended September 30, 2025 and 2024 was $8.4 million. Amortization expense related to deferred commissions for the nine months ended September 30, 2025 and 2024 was $24.9 million and $26.2 million, respectively. The Company evaluates the recoverability of deferred commissions at each balance sheet date and there were no impairments recorded during the nine months ended September 30, 2025 and 2024.

**Note 8 — Derivatives and Hedging**

The Company enters into a limited number of foreign currency forward exchange contracts to mitigate the effects of adverse fluctuations in foreign currency exchange rates on transactions entered into in the normal course of business that are denominated in foreign currencies that differ from the local functional currency. These contracts generally have short durations and are recorded at fair value with both realized and unrealized gains and losses recorded in other income, net in the Consolidated Statements of Operations because the Company does not designate these contracts as hedges for accounting purposes.

During the nine months ended September 30, 2025, the Company entered into ten foreign currency forward exchange contracts, all of which settled by September 30, 2025. Accordingly, as of September 30, 2025, there is no amount recorded in the Consolidated Balance Sheets for these contracts. During the nine months ended September 30, 2024, the Company entered into eight foreign currency forward exchange contracts, all of which settled by September 30, 2024. Accordingly, as of September 30, 2024, there is no amount recorded in the Consolidated Balance Sheets for these contracts.

The Company's derivative counterparties are investment grade financial institutions. The Company does not have any collateral arrangements with these counterparties and the derivative contracts do not contain credit risk-related contingent features. The table below provides information regarding gains (losses) recognized in the Consolidated Statements of Operations for the derivative contracts for the periods indicated (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| **Amount recorded in:** | **2025** | **2024** | **2025** | **2024** |
| Other income, net | $(81) | $84 | $256 | $68 |

---

**Note 9 — Fair Value Measurements**

The carrying amounts reflected in the Consolidated Balance Sheets for cash, accounts receivable, accounts payable, and accrued expenses approximate fair value due to their short-term maturities. The Company's financial instruments also include its outstanding variable-rate borrowings (refer to Note 5 – *Debt*). The Company believes that the carrying amount of its variable-rate borrowings reasonably approximate their fair values because the rates of interest on those borrowings reflect current market rates of interest.

Additionally, the Company measures certain financial assets at fair value on a recurring basis including cash equivalents and marketable investments. The fair values of these financial assets have been classified as Level 1, 2, or 3 within the fair value hierarchy as described in the accounting standards for fair value measurements:

Level 1 — Fair value based on quoted prices in active markets for identical assets or liabilities.

Level 2 — Fair value based on inputs other than Level 1 inputs that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 — Fair value based on unobservable inputs that are supported by little or no market activity and such inputs are significant to the fair value of the assets or liabilities.

------

The following table represents the Company's fair value hierarchy for its financial assets that are measured at fair value on a recurring basis (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Level 1** | **Level 2** | **Total** |
| Assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money market funds (1) | $65516 | $— | $65516 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketable investments (3) |  | 19798 | 19798 |
| Total Assets | $65516 | $19798 | $85314 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Level 1** | **Level 2** | **Total** |
| Assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Money market funds (2) | $52395 | $— | $52395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketable investments (3) |  | 12180 | 12180 |
| Total Assets | $52395 | $12180 | $64575 |

---

(1)U.S. based funds of $18.5 million are included in cash and cash equivalents and non-U.S. based funds of $47.0 million are included in marketable investments in the Consolidated Balance Sheets.

(2)U.S. based funds of $16.0 million are included in cash and cash equivalents and non-U.S. based funds of $36.4 million are included in marketable investments in the Consolidated Balance Sheets.

(3)Marketable investments have been initially valued at the transaction price and subsequently valued, at the end of the reporting period, utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation methods, including both income and market-based approaches and observable market inputs to determine value. These observable market inputs include reportable trades, benchmark yields, credit spreads, broker/dealer quotes, bids, offers, current spot rates and other industry and economic events.

During the nine months ended September 30, 2025, the Company did not transfer assets between levels of the fair value hierarchy. Additionally, there have been no changes to the valuation techniques for Level 2 assets.

**Note 10 – Non-Marketable Investments**

At September 30, 2025 and December 31, 2024, the carrying value of the Company's non-marketable investments, which were composed primarily of an interest in a standalone real-time feedback company (see Note 2 - *Divestiture*) and of interests in technology-related private equity funds, was $3.1 million and $3.2 million, respectively, and are included in other assets in the Consolidated Balance Sheets.

One of the Company's investments, with a carrying value of $2.6 million at September 30, 2025 is being accounted for using the cost method and, accordingly, is valued at cost less impairments, if any. The Company's other investment is accounted for using the equity method. Accordingly, the Company records its share of the investee's operating results each period, which are included in loss on investments, net in the Consolidated Statement of Operations. Gains and losses from non-marketable investments were immaterial during the three and nine months ended September 30, 2025 and 2024.

The Company uses the cumulative earnings approach to classify distributions received from equity method investments. During the nine months ended September 30, 2025, $1.4 million was distributed from the funds to the Company. This amount was included within other investing activity in the Consolidated Statements of Cash Flows as it was considered a return on investment. During the nine months ended September 30, 2024, no distributions were received from the funds.

**Note 11 — Income Taxes**

Forrester provides for income taxes on an interim basis according to management's estimate of the effective tax rate expected to be applicable for the full fiscal year. Certain items such as changes in tax rates, tax benefits or expense related to settlements of share-based awards, tax effects of foreign currency gains or losses, goodwill impairments, and the tax effect from the divestment of operations are treated as discrete items and are recorded in the period in which they arise.

Income tax expense for the nine months ended September 30, 2025 was $2.6 million resulting in an effective tax rate of (3.1)% for the period. Income tax expense for the nine months ended September 30, 2024 was $7.9 million resulting in an effective tax rate of 460.9% for the period.

The decrease in the effective tax rate during the 2025 period was primarily due to the goodwill impairment charge, which is not deductible for tax purposes, in addition to transactions in 2024 that increased the Company's tax expense and effective tax rate, including the divestiture of the FeedbackNow product line, foreign withholding taxes due to the dissolution of a foreign subsidiary,

------

and a valuation allowance recorded against non-realizable state net operating loss carryforwards due to the dissolution of a domestic subsidiary.

On July 4th, 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted, introducing changes to U.S. tax law. The effects of the OBBBA have been incorporated into the Company's estimated annual effective tax rate for the three and nine months ended September 30, 2025 and the impact was not material. The Company will continue to evaluate the changes from OBBBA, monitor developments, and assess its tax position as further guidance becomes available.

**Note 12 — Accumulated Other Comprehensive Loss ("AOCL")**

The components of accumulated other comprehensive loss are as follows (net of tax, in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **Marketable** | **Translation** |  |
|  | **Investments** | **Adjustment** | **Total AOCL** |
| Balance at June 30, 2025 | $37 | $(337) | $(300) |
| &nbsp;&nbsp;Foreign currency translation (1) |  | (893) | (893) |
| &nbsp;&nbsp;Unrealized gain, net of tax of $(7) | 21 |  | 21 |
| Balance at September 30, 2025 | $58 | $(1230) | $(1172) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Marketable** | **Translation** |  |
|  | **Investments** | **Adjustment** | **Total AOCL** |
| Balance at June 30, 2024 | $(36) | $(6690) | $(6726) |
| &nbsp;&nbsp;Foreign currency translation (1) |  | 3910 | 3910 |
| &nbsp;&nbsp;Reclassification adjustment for write-off of foreign currency translation loss (2) |  | 232 | 232 |
| &nbsp;&nbsp;Unrealized gain, net of tax of $(36) | 107 |  | 107 |
| Balance at September 30, 2024 | $71 | $(2548) | $(2477) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Marketable** | **Translation** |  |
|  | **Investments** | **Adjustment** | **Total AOCL** |
| Balance at December 31, 2024 | $29 | $(7775) | $(7746) |
| &nbsp;&nbsp;Foreign currency translation (1) |  | 6545 | 6545 |
| &nbsp;&nbsp;Unrealized gain, net of tax of $(9) | 29 |  | 29 |
| Balance at September 30, 2025 | $58 | $(1230) | $(1172) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Marketable** | **Translation** |  |
|  | **Investments** | **Adjustment** | **Total AOCL** |
| Balance at December 31, 2023 | $(60) | $(4511) | $(4571) |
| &nbsp;&nbsp;Foreign currency translation (1) |  | 1731 | 1731 |
| &nbsp;&nbsp;Reclassification adjustment for write-off of foreign currency translation loss (2) |  | 232 | 232 |
| &nbsp;&nbsp;Unrealized gain, net of tax of $(44) | 131 |  | 131 |
| Balance at September 30, 2024 | $71 | $(2548) | $(2477) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Company does not record tax provisions or benefits for the net changes in foreign currency translation adjustments as it intends to permanently reinvest undistributed earnings of its foreign subsidiaries.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The reclassification adjustment for the write-off of a foreign currency translation loss relates to the liquidation of a non-U.S. subsidiary during 2024 and is reported in restructuring costs in the Consolidated Statements of Operations.

**Note 13 — Net Loss Per Common Share**

Basic net loss per common share is computed by dividing net loss by the basic weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the diluted weighted average number of common shares and common equivalent shares outstanding during the period. The weighted average number of common equivalent shares outstanding has been determined in accordance with the treasury-stock method. Common equivalent shares consist of common stock issuable on the exercise of outstanding stock options and the vesting of restricted stock units.

------

Basic and diluted weighted average common shares are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Basic weighted average common shares outstanding | 19113 | 19065 | 19022 | 19147 |
| Weighted average common equivalent shares |  |  |  |  |
| Diluted weighted average common shares outstanding | 19113 | 19065 | 19022 | 19147 |
| Options and restricted stock units excluded from diluted<br> weighted average share calculation as effect would have<br> been anti-dilutive | 2524 | 1611 | 1626 | 1263 |

---

**Note 14 — Stockholders' Equity**

The components of stockholders' equity are as follows (in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|  | **Common Stock** | **Common Stock** |  |  | **Treasury Stock** | **Treasury Stock** | **Accumulated** |  |
|  | **Number<br>of<br>Shares** | **$0.01ParValue** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Number<br>of<br>Shares** | **Cost** | **Other<br>Comprehensive<br>Loss** | **Total<br>Stockholders'<br>Equity** |
| Balance at June 30, 2025 | 25361 | $254 | $298129 | $88575 | 6282 | $(227119) | $(300) | $159539 |
| Issuance of common stock under<br> stock plans, including tax effects | 150 | 1 | 238 |  |  |  |  | 239 |
| Repurchases of common stock |  |  |  |  | 240 | (2496) |  | (2496) |
| Stock-based compensation expense |  |  | 3388 |  |  |  |  | 3388 |
| Net loss |  |  |  | (2126) |  |  |  | (2126) |
| Net change in marketable investments,<br> net of tax |  |  |  |  |  |  | 21 | 21 |
| Foreign currency translation |  |  |  |  |  |  | (893) | (893) |
| Balance at September 30, 2025 | 25511 | $255 | $301755 | $86449 | 6522 | $(229615) | $(1172) | $157672 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|  | **Common Stock** | **Common Stock** |  |  | **Treasury Stock** | **Treasury Stock** | **Accumulated** |  |
|  | **Number<br>of<br>Shares** | **$0.01ParValue** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Number<br>of<br>Shares** | **Cost** | **Other<br>Comprehensive<br>Loss** | **Total<br>Stockholders'<br>Equity** |
| Balance at June 30, 2024 | 24897 | $249 | $285395 | $177300 | 5841 | $(219164) | $(6726) | $237054 |
| Issuance of common stock under<br> stock plans, including tax effects | 195 | 2 | 193 |  |  |  |  | 195 |
| Repurchases of common stock |  |  |  |  | 268 | (4969) |  | (4969) |
| Stock-based compensation expense |  |  | 3603 |  |  |  |  | 3603 |
| Net loss |  |  |  | (5798) |  |  |  | (5798) |
| Net change in marketable investments,<br> net of tax |  |  |  |  |  |  | 107 | 107 |
| Foreign currency translation |  |  |  |  |  |  | 4142 | 4142 |
| Balance at September 30, 2024 | 25092 | $251 | $289191 | $171502 | 6109 | $(224133) | $(2477) | $234334 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **Common Stock** | **Common Stock** |  |  | **Treasury Stock** | **Treasury Stock** | **Accumulated** |  |
|  | **Number<br>of<br>Shares** | **$0.01<br>Par<br>Value** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Number<br>of<br>Shares** | **Cost** | **Other<br>Comprehensive<br>Loss** | **Total<br>Stockholders'<br>Equity** |
| Balance at December 31, 2024 | 25119 | $251 | $292217 | $171934 | 6282 | $(227119) | $(7746) | $229537 |
| Issuance of common stock under<br> stock plans, including tax effects | 392 | 4 | 29 |  |  |  |  | 33 |
| Repurchases of common stock |  |  |  |  | 240 | (2496) |  | (2496) |
| Stock-based compensation expense |  |  | 9509 |  |  |  |  | 9509 |
| Net loss |  |  |  | (85485) |  |  |  | (85485) |
| Net change in marketable investments,<br> net of tax |  |  |  |  |  |  | 29 | 29 |
| Foreign currency translation |  |  |  |  |  |  | 6545 | 6545 |
| Balance at September 30, 2025 | 25511 | $255 | $301755 | $86449 | 6522 | $(229615) | $(1172) | $157672 |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|  | **Common Stock** | **Common Stock** |  |  | **Treasury Stock** | **Treasury Stock** | **Accumulated** |  |
|  | **Number<br>of<br>Shares** | **$0.01<br>Par<br>Value** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Number<br>of<br>Shares** | **Cost** | **Other<br>Comprehensive<br>Loss** | **Total<br>Stockholders'<br>Equity** |
| Balance at December 31, 2023 | 24684 | $247 | $278057 | $177681 | 5437 | $(211149) | $(4571) | $240265 |
| Issuance of common stock under<br> stock plans, including tax effects | 408 | 4 | (68) |  |  |  |  | (64) |
| Repurchases of common stock |  |  |  |  | 672 | (12984) |  | (12984) |
| Stock-based compensation expense |  |  | 11202 |  |  |  |  | 11202 |
| Net loss |  |  |  | (6179) |  |  |  | (6179) |
| Net change in marketable investments,<br> net of tax |  |  |  |  |  |  | 131 | 131 |
| Foreign currency translation |  |  |  |  |  |  | 1963 | 1963 |
| Balance at September 30, 2024 | 25092 | $251 | $289191 | $171502 | 6109 | $(224133) | $(2477) | $234334 |

---

*Equity Plans*

Restricted stock unit activity for the nine months ended September 30, 2025 is presented below (in thousands, except per share data):

---

| | | |
|:---|:---|:---|
|  |  | **Weighted-** |
|  |  | **Average** |
|  | **Number of** | **Grant Date** |
|  | **Shares** | **Fair Value** |
| Unvested at December 31, 2024 | 1253 | $27.42 |
| Granted | 1306 | 9.43 |
| Vested | (362) | 29.11 |
| Forfeited | (150) | 24.69 |
| Unvested at September 30, 2025 | 2047 | $15.84 |

---

Stock option activity for the nine months ended September 30, 2025 is presented below (in thousands, except per share data and contractual term):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | **Weighted -** | **Weighted -** |  |
|  |  | **Average** | **Average** |  |
|  |  | **Exercise** | **Remaining** | **Aggregate** |
|  | **Number** | **Price Per** | **Contractual** | **Intrinsic** |
|  | **of Shares** | **Share** | **Term (in years)** | **Value** |
| Outstanding at December 31, 2024 | 167 | $33.29 |  |  |
| Granted | 303 | 9.36 |  |  |
| Forfeited | (38) | 33.53 |  |  |
| Outstanding at September 30, 2025 | 432 | $16.48 | 8.63 | $376 |
| Exercisable at September 30, 2025 | 72 | $33.37 | 5.93 | $— |
| Vested and expected to vest at September 30, 2025 | 432 | $16.48 | 8.63 | $376 |

---

No stock options were exercised during the three and nine months ended September 30, 2025.

*Stock-Based Compensation*

Forrester recognizes the fair value of stock-based compensation over the requisite service period of the individual grantee, which generally equals the vesting period. Stock-based compensation was recorded in the following expense categories in the Consolidated Statements of Operations (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Cost of services and fulfillment | $2220 | $2142 | $6398 | $6777 |
| Selling and marketing | 414 | 528 | 913 | 1685 |
| General and administrative | 739 | 933 | 2520 | 2740 |
| Total | $3373 | $3603 | $9831 | $11202 |

---

------

Forrester utilizes the Black-Scholes valuation model for estimating the fair value of options granted under the equity incentive plans and shares subject to purchase under the employee stock purchase plan, which were valued using the following assumptions:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2025** | **2024** |
|  | **Employee Stock Purchase Plan** | **Employee Stock Purchase Plan** | **Employee Stock Purchase Plan** | **Equity Incentive Plans** | **Employee Stock Purchase Plan** |
| Average risk-free interest rate | 3.84% | 4.55% | 3.84% | 3.91% | 4.55% |
| Expected dividend yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Expected life | 0.5 Years | 0.5 Years | 0.5 Years | 4.50 Years | 0.5 Years |
| Expected volatility | 52% | 38% | 52% | 36% | 38% |
| Weighted average fair value | $2.90 | $4.86 | $2.90 | $3.38 | $4.86 |

---

*Liability-Classified Awards*

During 2025, the Company granted stock awards that are being accounted for as liability awards, such that the fair value of the awards are determined on a quarterly basis beginning at the grant date until final vesting. Changes in the fair value of liability-classified awards do not result in an impact to the Company's stockholders' equity balance. During the nine months ended September 30, 2025, the Company recorded $0.3 million of stock-based compensation expense related to these awards.

*Treasury Stock*

As of September 30, 2025, Forrester's Board of Directors had authorized an aggregate $610.0 million to purchase common stock under its stock repurchase program. The shares repurchased may be used, among other things, in connection with Forrester's equity incentive and purchase plans. During the three and nine months ended September 30, 2025, the Company repurchased approximately 0.2 million shares of common stock at an aggregate cost of approximately $2.5 million and the Company paid $44 thousand of excise taxes related to its 2024 purchases during the nine months ended September 30, 2025. During the three and nine months ended September 30, 2024, the Company repurchased approximately 0.3 million shares and 0.7 million shares of common stock at an aggregate cost of approximately $5.0 million and $13.0 million, respectively. From the inception of the program through September 30, 2025, the Company repurchased 18.2 million shares of common stock at an aggregate cost of $532.5 million.

**Note 15 — Restructuring and Related Costs**

In February 2024, the Company implemented a reduction in its workforce of approximately 3% across various geographies and functions to better align its cost structure with the revenue outlook for the year. The Company recorded $0.7 million of severance and related costs for this action during the fourth quarter of 2023, and $2.8 million during the first quarter of 2024. The Company also recorded a restructuring charge of $3.8 million during the first quarter of 2024 related to closing one floor of its offices located in San Francisco, California, of which $3.2 million related to an impairment of a right-of-use asset and $0.6 million related to an impairment of leasehold improvements. During the third quarter of 2024, the Company recorded an incremental $0.2 million impairment to its California office.

In January 2025, the Company implemented a reduction in its workforce of approximately 6% across various geographies and functions to better align its cost structure with the revenue outlook for the year. The Company recorded $4.2 million of severance and related costs for this action during the fourth quarter of 2024, $1.5 million during the first quarter of 2025, $0.4 million during the second quarter of 2025, and $(0.1) million during the third quarter of 2025. The Company expects the majority of the accrued restructuring and related costs as of September 30, 2025 to be paid by the end of 2025.

The following table rolls forward the activity in the restructuring accrual for the January 2025 action for the nine months ended September 30, 2025 (in thousands):

---

| | |
|:---|:---|
| Accrual at December 31, 2024 | $4132 |
| Additional restructuring and related costs | 1819 |
| Non-cash charge (included above) | (319) |
| Cash payments | (5341) |
| Foreign currency effect | 39 |
| Accrual at September 30, 2025 | $330 |

---

------

**Note 16 — Operating Segments**

The Company's chief operating decision-maker is the chief executive officer and the chief financial officer. The Company operates in three segments: Research, Consulting, and Events. These segments, which are also the Company's reportable segments, are based on the management structure of the Company and how the chief operating decision maker uses financial information to evaluate performance and determine how to allocate resources. The Company's products and services are delivered through each segment as described below.

The Research segment includes the revenues from all of the Company's research products as well as consulting revenues from advisory services (such as speeches and advisory days) delivered by the Company's research organization. Research segment costs include the cost of the organizations responsible for developing and delivering these products in addition to the costs of the product management organization responsible for product pricing and packaging, and the launch of new products. During the third quarter of 2024, the Company realigned its technology teams and as such certain technology costs are no longer reported as a direct expense of the Research segment, and are now reported within selling, marketing, administrative and other expenses in the tables below. As of January 1, 2025, the Company realigned its citations team costs such that these costs are now reported as a direct expense of the Research segment, whereas they were previously reported in selling, marketing, administrative and other expenses in the tables below. Prior period amounts have been recast to conform to the current presentation.

The Consulting segment includes the revenues and the related costs of the Company's project consulting organization. The project consulting organization delivers a majority of the Company's project consulting revenue. As of January 1, 2025, the Company realigned its content marketing partner costs such that these costs are now reported as a direct expense of the Consulting segment, whereas they were previously reported in selling, marketing, administrative and other expenses in the tables below. Prior period amounts have been recast to conform to the current presentation.

The Events segment includes the revenues and the costs of the organization responsible for developing and hosting its events. As of January 1, 2025, the Company realigned its events sponsorship sales team and as such the costs of this team were not reported as a direct expense of the Events segment during the first and second quarters of 2025. During the third quarter of 2025, the events sponsorship sales team was aligned back to Events and the costs of this team are now being reported as a direct expense of the Events segment. The nine months ended September 30, 2025 have been conformed to the current presentation for the entire period.

The Company evaluates reportable segment performance and allocates resources based on segment operating income (loss). Segment expenses include the direct expenses of each segment organization and exclude selling and marketing expenses, general and administrative expenses, stock-based compensation expense, depreciation expense, adjustments to incentive bonus compensation from target amounts, amortization of intangible assets, goodwill impairment, restructuring costs, loss from sale of divested operation, interest expense, credit loss expense on note receivable, other income, and losses on investments. The accounting policies used by the segments are the same as those used in the consolidated financial statements. The Company does not review or evaluate assets as part of segment performance. Accordingly, the Company does not identify or allocate assets by reportable segment.

------

The Company provides information by reportable segment in the tables below (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
| **Three Months Ended September 30, 2025** |  |  |  |  |
| Research revenues | $72652 | $— | $— | $72652 |
| Consulting revenues | 5487 | 15988 |  | 21475 |
| Events revenues |  |  | 168 | 168 |
| Total segment revenues | 78139 | 15988 | 168 | 94295 |
| Segment expenses (1): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation, benefits and related costs | (23230) | (7085) | (1262) | (31577) |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct cost of events |  |  | (405) | (405) |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional services | (1050) | (960) | 49 | (1961) |
| &nbsp;&nbsp;&nbsp;&nbsp;Billable expenses | (135) | (1336) |  | (1471) |
| &nbsp;&nbsp;&nbsp;&nbsp;Travel and entertainment | (453) | (143) | (51) | (647) |
| &nbsp;&nbsp;&nbsp;&nbsp;Software | (329) |  | (10) | (339) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment expenses (2) | (24) | (12) | (4) | (40) |
| Total segment expenses | (25221) | (9536) | (1683) | (36440) |
| Segment operating income (loss) | $52918 | $6452 | $(1515) | 57855 |
| Selling, marketing, administrative and other expenses |  |  |  | (51292) |
| Amortization of intangible assets |  |  |  | (2217) |
| Restructuring and related costs |  |  |  | 111 |
| Interest expense, credit loss expense on note receivable and other income |  |  |  | (6146) |
| Loss before income taxes |  |  |  | $(1689) |

---

(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.

(2)Other segment expenses for each reportable segment includes office supplies, maintenance, and training expenses.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
| **Three Months Ended September 30, 2024** |  |  |  |  |
| Research revenues | $77070 | $— | $— | $77070 |
| Consulting revenues | 4335 | 19034 |  | 23369 |
| Events revenues |  |  | 2088 | 2088 |
| Total segment revenues | 81405 | 19034 | 2088 | 102527 |
| Segment expenses (1): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation, benefits and related costs | (24636) | (7612) | (1431) | (33679) |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct cost of events |  |  | (1512) | (1512) |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional services | (2186) | (500) | (26) | (2712) |
| &nbsp;&nbsp;&nbsp;&nbsp;Billable expenses | (135) | (1990) |  | (2125) |
| &nbsp;&nbsp;&nbsp;&nbsp;Travel and entertainment | (486) | (101) | (34) | (621) |
| &nbsp;&nbsp;&nbsp;&nbsp;Software | (460) |  | (20) | (480) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment expenses (2) | (86) | (4) | (19) | (109) |
| Total segment expenses | (27989) | (10207) | (3042) | (41238) |
| Segment operating income (loss) | $53416 | $8827 | $(954) | 61289 |
| Selling, marketing, administrative and other expenses |  |  |  | (56904) |
| Amortization of intangible assets |  |  |  | (2404) |
| Restructuring and related costs |  |  |  | (937) |
| Loss from sale of divested operation |  |  |  | (1775) |
| Interest expense and other income |  |  |  | (343) |
| Loss before income taxes |  |  |  | $(1074) |

---

(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.

(2)Other segment expenses for each reportable segment includes office supplies, maintenance, and training expenses.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
| **Nine Months Ended September 30, 2025** |  |  |  |  |
| Research revenues | $218992 | $— | $— | $218992 |
| Consulting revenues | 16334 | 50070 |  | 66404 |
| Events revenues |  |  | 10434 | 10434 |
| Total segment revenues | 235326 | 50070 | 10434 | 295830 |
| Segment expenses (1): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation, benefits and related costs | (69196) | (21248) | (3976) | (94420) |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct cost of events |  |  | (9378) | (9378) |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional services | (5398) | (2483) | (28) | (7909) |
| &nbsp;&nbsp;&nbsp;&nbsp;Billable expenses | (320) | (4449) |  | (4769) |
| &nbsp;&nbsp;&nbsp;&nbsp;Travel and entertainment | (1470) | (385) | (106) | (1961) |
| &nbsp;&nbsp;&nbsp;&nbsp;Software | (1060) |  | (44) | (1104) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment expenses (2) | (95) | (26) | (28) | (149) |
| Total segment expenses | (77539) | (28591) | (13560) | (119690) |
| Segment operating income (loss) | $157787 | $21479 | $(3126) | 176140 |
| Selling, marketing, administrative and other expenses |  |  |  | (159885) |
| Amortization of intangible assets |  |  |  | (6651) |
| Goodwill impairment |  |  |  | (83895) |
| Restructuring and related costs |  |  |  | (1887) |
| Interest expense, credit loss expense on note receivable, other income and loss on investments |  |  |  | (6697) |
| Loss before income taxes |  |  |  | $(82875) |

---

(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.

(2)Other segment expenses for each reportable segment includes office supplies, maintenance, and training expenses.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
| **Nine Months Ended September 30, 2024** |  |  |  |  |
| Research revenues | $237314 | $— | $— | $237314 |
| Consulting revenues | 14478 | 56843 |  | 71321 |
| Events revenues |  |  | 15794 | 15794 |
| Total segment revenues | 251792 | 56843 | 15794 | 324429 |
| Segment expenses (1): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation, benefits and related costs | (77797) | (23481) | (4424) | (105702) |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct cost of events |  |  | (10446) | (10446) |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional services | (8947) | (1371) | (44) | (10362) |
| &nbsp;&nbsp;&nbsp;&nbsp;Billable expenses | (427) | (6109) |  | (6536) |
| &nbsp;&nbsp;&nbsp;&nbsp;Travel and entertainment | (1446) | (264) | (79) | (1789) |
| &nbsp;&nbsp;&nbsp;&nbsp;Software | (1410) |  | (28) | (1438) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment expenses (2) | (362) | (14) | (22) | (398) |
| Total segment expenses | (90389) | (31239) | (15043) | (136671) |
| Segment operating income | $161403 | $25604 | $751 | 187758 |
| Selling, marketing, administrative and other expenses |  |  |  | (169618) |
| Amortization of intangible assets |  |  |  | (7431) |
| Restructuring and related costs |  |  |  | (7643) |
| Loss from sale of divested operation |  |  |  | (1775) |
| Interest expense and other income |  |  |  | 421 |
| Income before income taxes |  |  |  | $1712 |

---

(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.

(2)Other segment expenses for each reportable segment includes office supplies, maintenance, and training expenses.

------

**Note 17 — Contingencies**

From time to time, the Company may be subject to legal proceedings and civil and regulatory claims that arise in the ordinary course of its business activities. Regardless of the outcome, legal proceedings and claims can have a material adverse effect on the Company because of defense and settlement costs, diversion of management resources, and other factors. It is the Company's policy to record accruals for legal contingencies to the extent that it has concluded that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated, and to expense costs associated with loss contingencies, including any related legal fees, as they are incurred. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision may change in the future due to new developments or changes in circumstances and could increase or decrease the Company's earnings in the period that the changes are made. The Company currently has no material pending litigation.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

***Overview***

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expects," "believes," "anticipates," "intends," "plans," "estimates," or similar expressions are intended to identify these forward-looking statements. Reference is made in particular to our statements about changing stakeholder expectations, migration of our clients into our Forrester Decisions products, product development, possible acquisitions, future dividends, future share repurchases, future growth rates, operating income and cash from operations, future deferred revenue, future compliance with financial covenants under our credit facility, future interest expense, anticipated increases in, and productivity of, our sales force and headcount, anticipated capital expenditures in connection with the lease for our principal headquarters and related tenant improvement allowance, the adequacy of our cash, and cash flows to satisfy our working capital and capital expenditures, the anticipated impact of accounting standards, and any future impairment charge we incur. These statements are based on our current plans and expectations and involve risks and uncertainties. Important factors that could cause actual future activities and results to differ include, among others, our ability to retain and enrich subscriptions to, and licenses of, our Research products and services, our ability to fulfill existing or generate new consulting engagements and advisory services, any adverse economic conditions, including from trade policies and tariffs, that result in a reduction in technology spending or demand for our products and services, our international operations expose us to a variety of operational risks which could negatively impact us, our ability to offer new products and services, the use of Generative AI in our business and by our clients and competitors, our dependence on key personnel, our ability to attract and retain qualified professional staff, our ability to respond to business and economic conditions and market trends, our business with the U.S. Government, the impact of our outstanding debt, competition and industry consolidation, possible variations in our quarterly operating results, the actual cost of capital expenditures that we undertake, concentration of our stock ownership, the possibility of network disruptions and security breaches, our ability to enforce and protect our intellectual property rights, compliance with privacy laws, taxation risks, any weakness identified in our system of internal controls, and any future impairment charge we incur. These risks are described more completely in our Annual Report on Form 10-K for the year ended December 31, 2024 and in this Quarterly Report on Form 10-Q. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

We derive revenues from subscriptions to our Research products and services, subscriptions to, and individual licenses of, electronic "reprints" of our Research, performing consulting projects and advisory services, and hosting events. We offer contracts for our products as either multi-year contracts or annual contracts, which are typically payable in advance on an annual basis. For certain contracts, we offer to invoice the contract price in multiple invoices throughout the year. Billings in excess of revenue recognized are recorded as deferred revenue. Subscription products are recognized as revenue over the term of the contract. Individual reprint licenses include an obligation to deliver a customer-selected research document and certain usage data provided through our platform, which represents two performance obligations. We recognize revenue for the performance obligation for the data portion of the reprint ratably over the license term. We recognize revenue for the performance obligation for the research document at the time of providing access to the document. Clients purchase consulting projects and advisory services independently and/or to supplement their access to our subscription-based products. Consulting project revenues, which are based upon fixed-fee agreements, are recognized as the services are provided. Advisory service revenues, such as speeches and advisory days, are recognized when the service is complete. Events revenues consist of ticket and sponsorship sales for a Forrester-hosted event, and revenue is recognized upon completion of each event.

Our primary operating expenses consist of cost of services and fulfillment, selling and marketing expenses, and general and administrative expenses. Cost of services and fulfillment represents the costs associated with the production and delivery of our products and services, including salaries, bonuses, employee benefits, and stock-based compensation expense for all personnel that produce and deliver our products and services, including all associated editorial, travel, and support services. Selling and marketing expenses include salaries, sales commissions, bonuses, employee benefits, stock-based compensation expense, travel expenses, promotional costs, and other costs incurred in marketing and selling our products and services. General and administrative expenses include the costs of the technology, operations, finance, and human resources groups and our other administrative functions, including salaries, bonuses, employee benefits, and stock-based compensation expense. Overhead costs such as facilities, net of sublease income, and annual fees for cloud-based information technology systems are allocated to these categories according to the number of employees in each group.

Our key metrics focus on our contract value ("CV") products. We are focusing on CV products as these products are our most profitable products and historically our contracts for CV products have renewed at high rates (as measured by our client retention and wallet retention metrics). Our CV products make up essentially all of our research revenues, and research revenues as a percentage of total revenues increased from approximately 73% for the nine months ended September 30, 2024 to approximately 74% for the nine months ended September 30, 2025.

------

We calculate CV at the foreign currency rates used for internal planning purposes each year. For comparative purposes, we have recast historical CV and wallet retention at the planned 2025 foreign currency rates. In addition, the recast metrics reflect the correction of an insignificant error. We have included the recast metrics below for the nine months ended September 30, 2024, and we have also provided recast metrics dating back to the third quarter of 2023, on the investor relations section of our website.

Contract value, client retention, wallet retention, and number of clients are metrics that we believe are important to understanding our research business. We define these metrics as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•*Contract value (CV)* — is defined as the value attributable to all of our recurring research-related contracts. Contract value is calculated as the annualized value of all contracts in effect at a specific point in time, without regard to how much revenue has already been recognized. Contract value primarily consists of subscription-based products for which revenue is recognized on a ratable basis, except for the entitlements embedded in our subscription products, such as event tickets and advisory sessions, for which the revenue is recognized when the item is delivered. Contract value also includes our reprint products, as these products are used throughout the year by our clients and are typically renewed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•*Client retention* — represents the percentage of client companies (defined as all clients that buy a CV product) at the prior year measurement date that have active contracts at the current year measurement date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•*Wallet retention —* represents a measure of the CV we have retained with clients over a twelve-month period, including increases or decreases in retained client CV during the period. Wallet retention is calculated on a percentage basis by dividing the annualized contract value of our current clients, who were also clients a year ago, by the total annualized contract value from a year ago.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•*Clients* — is calculated at the enterprise level as all clients that have an active CV contract.

Client retention and wallet retention are not necessarily indicative of the rate of future retention of our revenue base. A summary of our key metrics is as follows (dollars in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of** | **As of** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Contract value | $288.1 | $309.8 | $(21.7) | (7%) |
| Client retention | 74% | 73% | 1 point |  |
| Wallet retention | 86% | 88% | (2) points |  |
| Number of clients | 1774 | 2002 | (228) | (11%) |

---

Contract value at September 30, 2025 decreased by 7% compared to the prior year period due to wallet retention being at 86% for the period (representing retention and enrichment of the prior year CV base) and new client acquisition not fully offsetting the net retention loss. Client retention increased by 1 percentage point at September 30, 2025 compared to the prior year period, and was consistent compared to the prior quarter. However, wallet retention decreased by 2 percentage points at September 30, 2025 compared to the prior year period, and increased by 1 percentage point compared to the prior quarter. The decline in wallet retention compared to the prior year period was primarily due to lower enrichment of contracts as they renewed during the current year period.

Management's discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including but not limited to, those related to our revenue recognition, credit losses on the note receivable, goodwill, intangible and other long-lived assets, and income taxes. Management bases its estimates on historical experience, data available at the time the estimates are made, and various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting estimates are described in our Annual Report on Form 10-K for the year ended December 31, 2024 and in this Quarterly Report on Form 10-Q.

------

**Results of Operations**

The following table sets forth our statement of operations as a percentage of total revenues for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research revenues | 77.0% | 75.2% | 74.1% | 73.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting revenues | 22.8 | 22.8 | 22.4 | 22.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Events revenues | 0.2 | 2.0 | 3.5 | 4.9 |
| Total revenues | 100.0 | 100.0 | 100.0 | 100.0 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of services and fulfillment | 40.0 | 41.1 | 42.9 | 42.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and marketing | 38.2 | 37.3 | 36.9 | 36.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 13.2 | 15.4 | 13.2 | 13.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 1.6 | 1.9 | 1.6 | 1.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 2.4 | 2.3 | 2.2 | 2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment |  |  | 28.4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs | (0.1) | 1.0 | 0.6 | 2.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from sale of divested operation |  | 1.7 |  | 0.5 |
| Income (loss) from operations | 4.7 | (0.7) | (25.8) | 0.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (0.7) | (0.8) | (0.7) | (0.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on investments, net |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit loss expense on note receivable | (6.8) |  | (2.4) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | 1.0 | 0.5 | 0.9 | 0.8 |
| Income (loss) before income taxes | (1.8) | (1.0) | (28.0) | 0.5 |
| Income tax expense | 0.5 | 4.7 | 0.9 | 2.4 |
| Net loss | (2.3%) | (5.7%) | (28.9%) | (1.9%) |

---

***Three and Nine Months Ended September 30, 2025 and 2024***

***Revenues***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
|  | **(dollars in millions)** | **(dollars in millions)** |  |  |
| Total revenues | $94.3 | $102.5 | $(8.2) | (8%) |
| Research revenues | $72.7 | $77.1 | $(4.4) | (6%) |
| Consulting revenues | $21.5 | $23.4 | $(1.9) | (8%) |
| Events revenues | $0.2 | $2.1 | $(1.9) | (92%) |
| Revenues attributable to customers outside of <br> the U.S. | $23.3 | $23.6 | $(0.3) | (1%) |
| Percentage of revenue attributable to customers <br> outside of the U.S. | 25% | 23% | 2 points |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
|  | **(dollars in millions)** | **(dollars in millions)** |  |  |
| Total revenues | $295.8 | $324.4 | $(28.6) | (9%) |
| Research revenues | $219.0 | $237.3 | $(18.3) | (8%) |
| Consulting revenues | $66.4 | $71.3 | $(4.9) | (7%) |
| Events revenues | $10.4 | $15.8 | $(5.4) | (34%) |
| Revenues attributable to customers outside of <br> the U.S. | $66.7 | $73.4 | $(6.7) | (9%) |
| Percentage of revenue attributable to customers <br> outside of the U.S. | 23% | 23% |  |  |

---

------

Research revenues are recognized as revenue primarily on a ratable basis over the term of the contracts, which are generally 12 or 24-month periods. Research revenues decreased 6% and 8% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods, primarily due to the decrease in CV, as discussed above, and the divestiture of the FeedbackNow product line in the third quarter of 2024, which resulted in an approximate 2% decline in revenue in both periods. From a product perspective, the decrease in revenues during both the three and nine months ended September 30, 2025 was primarily due to a decline in revenue from subscriptions to our research and to the effect of the divestiture of the FeedbackNow product line, partially offset by an increase in reprint revenue. Research subscription products, including our subscription reprint product that was launched in the third quarter of 2024, declined 5% during both the three and nine months ended September 30, 2025 primarily due to revenue growth from our Forrester Decisions and subscription reprint products being offset by revenue declines from our heritage research products.

Consulting revenues decreased 8% and 7% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. The decrease in revenues during the three and nine months ended September 30, 2025 was due to a decrease in delivery of consulting services due to lower client bookings.

Events revenues decreased 92% and 34% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. The decrease in revenues during the three months ended September 30, 2025 was primarily due to us holding one of our larger U.S. events in the fourth quarter of 2025 compared to the third quarter of 2024. The decrease in revenues during the nine months ended September 30, 2025 was also due to a decrease in sponsorship revenues for the events held during the period.

Refer to the "Segments Results" section below for a discussion of revenues and expenses by segment.

***Cost of Services and Fulfillment***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Cost of services and fulfillment (dollars in millions) | $37.7 | $42.2 | $(4.5) | (11%) |
| Cost of services and fulfillment as a percentage of <br> total revenues | 40% | 41% | (1) point |  |
| Service and fulfillment employees <br> (at end of period) | 653 | 690 | (37) | (5%) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Cost of services and fulfillment (dollars in millions) | $127.0 | $138.0 | $(11.1) | (8%) |
| Cost of services and fulfillment as a percentage of <br> total revenues | 43% | 43% |  |  |

---

Cost of services and fulfillment expenses decreased 11% during the three months ended September 30, 2025 compared to the prior year period. The decrease was primarily due to (1) a $1.5 million decrease in compensation and benefit costs due to a decrease in headcount, (2) a $1.3 million decrease in professional services costs primarily due to a decrease in billable fees and the effect of the divestiture of the FeedbackNow product line, partially offset by an increase in contractor costs, (3) a $1.1 million decrease in event expenses primarily due to holding one of our larger U.S. events in the fourth quarter of 2025 compared to the third quarter of 2024, and (4) a $0.7 million decrease in facilities costs primarily due to a decrease in lease expense.

Cost of services and fulfillment expenses decreased 8% during the nine months ended September 30, 2025 compared to the prior year period. The decrease was primarily due to (1) a $4.6 million decrease in compensation and benefit costs due to a decrease in headcount, partially offset by an increase in incentive bonus costs, (2) a $3.8 million decrease in professional services costs primarily due to a decrease in billable fees, consulting fees, and the effect of the divestiture of the FeedbackNow product line, partially offset by an increase in contractor costs, (3) a $1.5 million decrease in facilities costs primarily due to a decrease in lease expense and (4) a $1.1 million decrease in event expenses as discussed for the three month period.

***Selling and Marketing***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Selling and marketing expenses (dollars in millions) | $36.0 | $38.3 | $(2.3) | (6%) |
| Selling and marketing expenses as a percentage of <br> total revenues | 38% | 37% | 1 point |  |
| Selling and marketing employees (at end of period) | 604 | 663 | (59) | (9%) |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Selling and marketing expenses (dollars in millions) | $109.0 | $117.9 | $(8.9) | (8%) |
| Selling and marketing expenses as a percentage of <br> total revenues | 37% | 36% | 1 point |  |

---

Selling and marketing expenses decreased 6% during the three months ended September 30, 2025 compared to the prior year period. The decrease was primarily due to (1) a $1.8 million decrease in compensation and benefit costs due to a decrease in headcount and (2) a $0.6 million decrease in facilities costs primarily due to a decrease in lease expense.

Selling and marketing expenses decreased 8% during the nine months ended September 30, 2025 compared to the prior year period. The decrease was primarily due to (1) a $6.6 million decrease in compensation and benefit costs due to a decrease in headcount and commissions expense, partially offset by an increase in incentive bonus costs, (2) a $1.0 million decrease in professional services costs primarily due to a decrease in consulting fees, (3) a $0.9 million decrease in facilities costs primarily due to a decrease in lease expense and (4) a $0.8 million decrease in stock compensation expense. These decreases were partially offset by a $0.9 million increase in travel and entertainment expenses.

***General and Administrative***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| General and administrative expenses (dollars in <br> millions) | $12.5 | $15.7 | $(3.3) | (21%) |
| General and administrative expenses as a percentage <br> of total revenues | 13% | 15% | (2) points |  |
| General and administrative employees (at end of <br> period) | 228 | 255 | (27) | (11%) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| General and administrative expenses (dollars in <br> millions) | $38.9 | $44.2 | $(5.3) | (12%) |
| General and administrative expenses as a percentage <br> of total revenues | 13% | 14% | (1) point |  |

---

General and administrative expenses decreased 21% during the three months ended September 30, 2025 compared to the prior year period. The decrease was primarily due to a $2.0 million decrease in compensation and benefit costs due to a decrease in headcount.

General and administrative expenses decreased 12% during the nine months ended September 30, 2025 compared to the prior year period. The decrease was primarily due to (1) a $3.5 million decrease in compensation and benefit costs due to a decrease in headcount, partially offset by an increase in incentive bonus costs, (2) a $0.6 million decrease in software costs and (3) a $0.5 million decrease in non-income taxes.

***Depreciation***

The fluctuation for depreciation expense was immaterial during the three months ended September 30, 2025 compared to the prior year period. Depreciation expense decreased by $1.4 million during the nine months ended September 30, 2025 compared to the prior year period due to certain software assets becoming fully depreciated.

***Amortization of Intangible Assets***

The fluctuation for amortization expense was immaterial during the three months ended September 30, 2025 compared to the prior year period. Amortization expense decreased by $0.8 million during the nine months ended September 30, 2025 compared to the prior year period primarily due to the divestiture of the FeedbackNow product line.

***Goodwill Impairment***

As a result of the substantial and sustained decline in our stock price and our overall market capitalization from mid-February 2025 through March 31, 2025, along with other qualitative considerations, including the continued impact from the conditions in the

------

The income approach was based upon projected future cash flows that were discounted to present value. The key underlying assumptions included forecasted revenues, operating expenses, terminal rate, as well as an applicable discount rate for each reporting unit. The key assumptions in the market approach were the earnings multiple and market participant acquisition premium. Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions that we deemed to be reasonable. Changes in the estimates or assumptions used in the quantitative impairment test could materially affect the determination of fair value of our reporting units and the associated goodwill impairment assessment. Potential events and circumstances that could have an adverse impact on our estimates and assumptions include, but are not limited to, lower than expected bookings growth, increases in costs, and other macroeconomic factors.

We concluded that a triggering event did not occur during the three months ended June 30, 2025 and September 30, 2025 and as such, a quantitative impairment test of goodwill was not required during either period. We will continue to monitor relevant facts and circumstances, including future changes in our stock price. We may be required to record additional goodwill impairment charges. While we cannot predict if or when additional goodwill impairments may occur, future goodwill impairments could have material adverse effects on our results of operations and financial condition.

***Restructuring and Related Costs***

In February 2024, we implemented a reduction in our workforce of approximately 3% across various geographies and functions to better align our cost structure with the revenue outlook for the year. We recorded $0.7 million of severance and related costs for this action during the fourth quarter of 2023, and $2.8 million during the first quarter of 2024. We recorded a restructuring charge of $3.8 million during the first quarter of 2024 related to closing one floor of our offices in San Francisco, California, of which $3.2 million related to an impairment of a right-of-use asset and $0.6 million related to an impairment of leasehold improvements.

During the third quarter of 2024, we recorded an additional restructuring charge of $0.7 million related to the prior closure of both floors of our offices located in San Francisco, California, of which $0.4 million related to an impairment of the right-of-use assets and $0.3 million related to an impairment of leasehold improvements. Also, during the third quarter of 2024, we recognized $0.2 million of expense from the write-off of foreign currency translation adjustments related to the liquidation of a small foreign operation.

In January 2025, we implemented a reduction in our workforce of approximately 6% across various geographies and functions to better align our cost structure with the revenue outlook for the year. We recorded $4.2 million of severance and related costs for this action during the fourth quarter of 2024, $1.5 million during the first quarter of 2025, $0.4 million during the second quarter of 2025, and $(0.1) million during the third quarter of 2025.

***Loss from Sale of Divested Operation***

Loss from sale of divested operation of $1.8 million was attributable to the sale of our FeedbackNow product line in August 2024.

***Interest Expense***

Interest expense consists of interest on our borrowings. The fluctuation in interest expense was immaterial during the three and nine months ended September 30, 2025 compared to the prior year periods.

***Loss on Investments, Net***

Loss on investments, net primarily represents our share of equity method investment gains and losses from our technology-related investment funds. The fluctuation for loss on investments, net was immaterial during the three and nine months ended September 30, 2025 compared to the prior year periods.

***Credit Loss Expense on Note Receivable***

Credit loss expense on note receivable consists of an allowance for credit losses on a note receivable from the divestiture of FeedbackNow during the third quarter of 2024.

------

***Other Income, Net***

Other income, net primarily consists of interest income, gains and losses on foreign currency, and gains and losses on foreign currency forward contracts. Other income, net increased by $0.5 million during the three months ended September 30, 2025 compared to the prior year period primarily due to a decrease in foreign currency losses. The fluctuation in other income, net was immaterial during the nine months ended September 30, 2025 compared to the prior year period.

***Income Tax Expense***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Provision for income taxes (dollars in millions) | $0.4 | $4.7 | $(4.3) | (91%) |
| Effective tax rate | (26%) | (440%) | 414 points |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | **Absolute** | **Percentage** |
|  | **September 30,** | **September 30,** | **Increase** | **Increase** |
|  | **2025** | **2024** | **(Decrease)** | **(Decrease)** |
| Provision for income taxes (dollars in millions) | $2.6 | $7.9 | $(5.3) | (67%) |
| Effective tax rate | (3%) | 461% | (464) points |  |

---

The decrease in the effective tax rate during the nine months ended September 30, 2025 compared to the prior year period is primarily due to the goodwill impairment charge, which is not deductible for tax purposes, in addition to transactions in 2024 that increased our tax expense and effective tax rate, including the divestiture of the FeedbackNow product line, foreign withholding taxes due to the dissolution of a foreign subsidiary, and a valuation allowance recorded against non-realizable state net operating loss carryforwards due to the dissolution of a domestic subsidiary. For the full year 2025, we anticipate that our effective tax rate will be in the range of negative 2% to 5%.

***Segment Results***

We operate in three segments: Research, Consulting, and Events. These segments, which are also our reportable segments, are based on our management structure and how management uses financial information to evaluate performance and determine how to allocate resources. Our products and services are delivered through each segment as described below.

The Research segment includes the revenues from all of our research products as well as consulting revenues from advisory services (such as speeches and advisory days) delivered by our research organization. Research segment costs include the cost of the organizations responsible for developing and delivering these products in addition to the costs of the product management organization that is responsible for product pricing and packaging, and the launch of new products. During the third quarter of 2024, we realigned our technology teams and as such certain technology costs are no longer reported as a direct expense of the Research segment in the table below. As of January 1, 2025, we realigned our citations team costs such that these costs are now reported as a direct expense of the Research segment in the table below. Prior period amounts have been recast to conform to the current presentation.

The Consulting segment includes the revenues and the related costs of our project consulting organization. The project consulting organization delivers a majority of our project consulting revenue. As of January 1, 2025, we realigned our content marketing partner costs such that these costs are now reported as a direct expense of the Consulting segment in the table below. Prior period amounts have been recast to conform to the current presentation.

The Events segment includes the revenues and the costs of the organization responsible for developing and hosting our events. As of January 1, 2025, the Company realigned its events sponsorship sales team and as such the costs of this team were not reported as a direct expense of the Events segment during the first and second quarters of 2025. During the third quarter of 2025, the events sponsorship sales team was aligned back to Events and the costs of this team are now being reported as a direct expense of the Events segment. The nine months ended September 30, 2025 have been conformed to the current presentation for the entire period.

We evaluate reportable segment performance and allocate resources based on segment operating income (loss). Segment expenses include the direct expenses of each segment organization and exclude selling and marketing expenses, general and administrative expenses, stock-based compensation expense, depreciation expense, adjustments to incentive bonus compensation from target amounts, amortization of intangible assets, goodwill impairment, restructuring costs, loss from sale of divested operation, interest expense, credit loss expense on note receivable, other income, and losses on investments. The accounting policies used by the segments are the same as those used in the consolidated financial statements.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
|  | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** |
| **Three Months Ended September 30, 2025** |  |  |  |  |
| Research revenues | $72652 | $— | $— | $72652 |
| Consulting revenues | 5487 | 15988 |  | 21475 |
| Events revenues |  |  | 168 | 168 |
| Total segment revenues | 78139 | 15988 | 168 | 94295 |
| Segment expenses | (25221) | (9536) | (1683) | (36440) |
| Segment operating income (loss) | 52918 | 6452 | (1515) | 57855 |
| Year over year revenue change | (4%) | (16%) | (92%) | (8%) |
| Year over year expense change | (10%) | (7%) | (45%) | (12%) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
|  | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** |
| **Three Months Ended September 30, 2024** |  |  |  |  |
| Research revenues | $77070 | $— | $— | $77070 |
| Consulting revenues | 4335 | 19034 |  | 23369 |
| Events revenues |  |  | 2088 | 2088 |
| Total segment revenues | 81405 | 19034 | 2088 | 102527 |
| Segment expenses | (27989) | (10207) | (3042) | (41238) |
| Segment operating income (loss) | 53416 | 8827 | (954) | 61289 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
|  | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** |
| **Nine Months Ended September 30, 2025** |  |  |  |  |
| Research revenues | $218992 | $— | $— | $218992 |
| Consulting revenues | 16334 | 50070 |  | 66404 |
| Events revenues |  |  | 10434 | 10434 |
| Total segment revenues | 235326 | 50070 | 10434 | 295830 |
| Segment expenses | (77539) | (28591) | (13560) | (119690) |
| Segment operating income (loss) | 157787 | 21479 | (3126) | 176140 |
| Year over year revenue change | (7%) | (12%) | (34%) | (9%) |
| Year over year expense change | (14%) | (8%) | (10%) | (12%) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Research Segment** | **Consulting Segment** | **Events Segment** | **Consolidated** |
|  | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** | **(dollars in thousands)** |
| **Nine Months Ended September 30, 2024** |  |  |  |  |
| Research revenues | $237314 | $— | $— | $237314 |
| Consulting revenues | 14478 | 56843 |  | 71321 |
| Events revenues |  |  | 15794 | 15794 |
| Total segment revenues | 251792 | 56843 | 15794 | 324429 |
| Segment expenses | (90389) | (31239) | (15043) | (136671) |
| Segment operating income | 161403 | 25604 | 751 | 187758 |

---

Research segment revenues decreased 4% and 7% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. For the three and nine months ended September 30, 2025, research product revenues within this segment decreased 6% and 8%, respectively, primarily due to the decrease in CV, as discussed above, as well as due to the divestiture of the FeedbackNow product line in the third quarter of 2024, partially offset by an increase in reprint revenue. For the three and nine months ended September 30, 2025, consulting product revenues within this segment increased 27% and 13%, respectively, primarily due to increased delivery of advisory services by our research analysts.

------

Research segment expenses decreased 10% and 14% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. The decrease in expenses during the three months ended September 30, 2025 was primarily due to (1) a $1.4 million decrease in compensation and benefit costs primarily due to a decrease in headcount and (2) a $1.1 million decrease in professional services due to the effect of the divestiture of the FeedbackNow product line, partially offset by an increase in contractor costs. The decrease in expenses during the nine months ended September 30, 2025 was primarily due to (1) a $8.6 million decrease in compensation and benefit costs primarily due to a decrease in headcount and (2) a $3.5 million decrease in professional services due to a decrease in consulting fees and the effect of the divestiture of the FeedbackNow product line, partially offset by an increase in contractor costs.

Consulting segment revenues decreased 16% and 12% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. The decrease in revenues during the three and nine months ended September 30, 2025 was due to a decrease in delivery of consulting services due to lower client bookings.

Consulting segment expenses decreased 7% and 8% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. The decrease in expenses during the three months ended September 30, 2025 was primarily due to (1) a $0.7 million decrease in billable fees and (2) a $0.5 million decrease in compensation and benefit costs primarily due to a decrease in headcount. These decreases were partially offset by a $0.5 million increase in professional services due primarily to an increase in contractor costs. The decrease in expenses during the nine months ended September 30, 2025 was primarily due to (1) a $2.2 million decrease in compensation and benefit costs primarily due to a decrease in headcount and (2) a $1.7 million decrease in billable fees. These decreases were partially offset by a $1.1 million increase in professional services due primarily to an increase in contractor costs.

Event segment revenues decreased 92% and 34% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods. The decrease in revenues during the three months ended September 30, 2025 was primarily due to us holding one of our larger U.S. events in the fourth quarter of 2025 compared to the third quarter of 2024. The decrease in revenues during the nine months ended September 30, 2025 was also due to a decrease in sponsorship revenues for the events held during the period.

Event segment expenses decreased 45% and 10% during the three and nine months ended September 30, 2025, respectively, compared to the prior year periods due primarily to the move of a U.S. event that occurred in the third quarter of 2024 to the fourth quarter of 2025.

**Liquidity and Capital Resources**

We have historically financed our operations primarily through funds generated from operations. Research revenues, which constituted approximately 74% of our revenues during the nine months ended September 30, 2025, are generally renewable and are typically payable in advance. We generated cash from operating activities of $24.3 million during the nine months ended September 30, 2025 and used cash in operating activities of $2.0 million during the nine months ended September 30, 2024. The $26.3 million increase in cash from operations for the nine months ended September 30, 2025 compared to the prior year period was primarily due to a $21.1 million decrease in cash used for accrued expenses resulting primarily from a decrease in the payment of year end incentive compensation during 2025 as compared to the prior year period, and the payment of a legal settlement during the prior year period.

During the nine months ended September 30, 2025, we used cash in investing activities of $15.7 million primarily from $15.4 million in net purchases of marketable investments and $1.9 million of purchases of property and equipment, primarily consisting of computer software, partially offset by a $1.4 million distribution received from an equity method investment. During the nine months ended September 30, 2024, we generated cash from investing activities of $4.8 million primarily from $6.0 million in proceeds from the sale of the FeedbackNow product line and $1.6 million in net maturities and sales of marketable investments, partially offset by $2.7 million of purchases of property and equipment, primarily consisting of computer software.

On April 11, 2025, we entered into a third amendment of our lease, and a new lease, for our principal headquarters located in Cambridge, Massachusetts. The effect of these agreements was to early terminate the original lease with respect to the first, second and third floors of the facility on or before May 31, 2026, while also extending the lease term with respect to the fourth, fifth and six floors of the facility through June 30, 2039. As a result of reducing the number of floors that we will occupy, we intend to renovate floors four to six and currently expect to incur capital expenditures of approximately $33.0 million, of which $6.0 million is expected to be incurred during the fourth quarter of 2025 and the remainder will be incurred in the first half of 2026. Under the terms of the lease agreement, the landlord is providing a tenant improvement allowance of $17.2 million, of which $0.3 million is expected to be received in the fourth quarter of 2025 and the remainder in the first half of 2026. Future cash receipts for the tenant improvement allowance will be classified as operating cash flows in the cash flow statement.

During the nine months ended September 30, 2025, we used $2.4 million of cash in financing activities primarily due to $2.4 million for purchases of our common stock and $1.2 million in taxes paid related to net share settlements of restricted stock units, partially offset by $1.3 million of net proceeds from the issuance of common stock under our stock-based incentive plans. We used

------

$13.0 million of cash in financing activities during the nine months ended September 30, 2024 primarily due to $13.0 million for purchases of our common stock and $2.5 million in taxes paid related to net share settlements of restricted stock units, partially offset by $2.4 million of net proceeds from the issuance of common stock under our stock-based incentive plans. As of September 30, 2025, our remaining stock repurchase authorization was approximately $77.5 million.

We have a credit facility that provides up to $150.0 million of revolving credit commitments. The amount outstanding under the credit facility was $35.0 million at September 30, 2025 and the facility expires in December of 2026. The credit facility permits us to increase the revolving credit commitments in an aggregate principal amount up to $50.0 million, subject to approval by the administrative agent and certain customary terms and conditions.

The credit facility contains certain customary restrictive loan covenants, including among others, financial covenants that apply a maximum leverage ratio, minimum interest coverage ratio, and maximum annual capital expenditures. The negative covenants limit, subject to various exceptions, our ability to incur additional indebtedness, create liens on assets, merge, consolidate, liquidate or dissolve any part of the company, sell assets, change fiscal year, or enter into certain transactions with affiliates and subsidiaries. We were in full compliance with the covenants as of September 30, 2025 and expect to continue to be in compliance through the next 12 months.

Additional future contractual cash obligations extending over the next 12 months and beyond primarily consist of operating lease payments. We lease office space under non-cancelable operating lease agreements (refer to Note 6 – *Leases* in the Notes to Consolidated Financial Statements for additional information). The remaining duration of non-cancelable office space leases ranges from less than 1 year to 14 years. Remaining lease payments within one year, within two to three years, within four to five years, and after five years from September 30, 2025, are $2.8 million, $15.9 million, $13.2 million, and $44.2 million respectively.

In addition to the contractual cash commitments included above, we have other payables and liabilities that may be legally enforceable but are not considered contractual commitments.

As of September 30, 2025, we had cash, cash equivalents, and marketable investments of $132.0 million. This balance includes $87.9 million held outside of the U.S. If the cash outside of the U.S. is needed for operations in the U.S., we would be required to accrue and pay U.S. state taxes and may be required to pay withholding taxes to foreign jurisdictions to repatriate these funds. However, our intent is to permanently reinvest these funds outside of the U.S. and our current plans do not demonstrate a need to repatriate these funds for our U.S. operations. We believe that our current cash balance and cash flows from operations will satisfy working capital, financing activities, and capital expenditure requirements for the next twelve months and to meet our known long-term cash requirements.

**Recent Accounting Pronouncements**

Refer to Note 1 – *Interim Consolidated Financial Statements* in the Notes to Consolidated Financial Statements for a full description of recent accounting pronouncements including the expected dates of adoption and effects on results of operations and financial condition. There have been no material changes to the critical accounting policies and estimates previously disclosed in that report.

**Critical Accounting Policies and Estimates**

For information regarding our critical accounting policies and estimates, please refer to Note 1, "Summary of Significant Accounting Policies" and Item 7, "Critical Accounting Estimates" contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The critical accounting estimate below supplements the critical accounting estimates discussed in our Annual Report on Form 10-K for the year ended December 31, 2024.

*Allowance for Credit Losses on Note Receivable*

As part of the proceeds from the sale of a non-core product line in August 2024, we received a note receivable with an original face value of $9.0 million. We measure the note receivable on an amortized cost basis and record an estimate of any expected credit losses on the note receivable as an allowance for credit losses each reporting period. The allowance represents our best estimate of credit losses over the contractual life of the note and is calculated using the loss given default method. This method involves estimating the likelihood that the borrower will default on its obligations and the expected losses from such default. Our estimates under the loss given default method reflect the borrower's liquidity position and our judgments about their risk of default and expected financial performance as of the balance sheet date.

The allowance for credit losses is reported as a valuation account on the balance sheet that is deducted from the note receivable's amortized cost basis and is included in credit loss expense on note receivable in the Consolidated Statement of Operations. As of September 30, 2025, the balance of the note receivable, inclusive of capitalized interest at the stated rate of 8%, is $9.9 million. The carrying value of the note, net of the cumulative allowance for credit losses, is $2.6 million. We will update our assessment of expected credit loss each quarter and if the borrower's financial condition worsens in the future, we could be required to record an additional allowance for credit loss. If any amount of the note is determined by the Company to be uncollectible due to the

------

borrower's failure to meet repayment terms or due to the borrower's deteriorating financial condition, the write-off amount, reduced by any previously recorded allowances, would also be recorded as a credit loss expense on note receivable. Alternatively, if the borrower's financial condition improves, we could be required to reverse all or a portion of the previously recorded allowance for credit loss.

------

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

There have been no material changes in our assessment of our sensitivity to market risk since our presentation set forth in Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," in our Annual Report on Form 10-K for the year ended December 31, 2024.

**ITEM 4. CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

We maintain "disclosure controls and procedures," as such term is defined under Securities Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025. Based upon their evaluation and subject to the foregoing, the principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance as of that date.

**Changes in Internal Control Over Financial Reporting**

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) of the Exchange Act) that occurred during the quarter ended September 30, 2025, which has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

The information set forth in the "Note 17 - *Contingencies*", in Part I, Item 1 of this Quarterly Report is incorporated herein by reference.

**ITEM 1A. RISK FACTORS**

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, "Item 1A: Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, which could materially affect our business, financial condition or future results. The risk factors below supplement and update the risk factors and information discussed in our Annual Report on Form 10-K for the year ended December 31, 2024. The risk factors described in our Annual Report on Form 10-K remain applicable to our business. The risks described in this Form 10-Q and in our Annual Report on Form 10-K are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

**Risks Relating to our Business**

***We have recently recorded a substantial impairment charge. Any future impairments of our assets could negatively impact our results of operations.***

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

Through September 30, 2025, our Board of Directors authorized an aggregate $610.0 million to purchase common stock under our stock repurchase program. During the quarter ended September 30, 2025, we purchased the following shares of our common stock under the stock repurchase program:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  |  |  | **Maximum Approximate Dollar** |
|  |  |  | **Total Number of Shares** | **Value of Shares that May** |
|  | **Total Number of** | **Average Price** | **Purchased as Part of Publicly** | **Yet be Purchased** |
|  | **Shares Purchased** | **Paid per Share** | **Announced Plans or Programs** | **Under the Plans or Programs** |
| **Period** | **(#)** | **($)** | **(#)** | **(In thousands)** |
| July 1 - July 31 |  | $— |  | $79964 |
| August 1 - August 31 |  | $— |  | $79964 |
| September 1 - September 30 | 239762 | $10.41 | 239762 | $77468 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total for the quarter | 239762 |  | 239762 |  |

---

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

Not applicable.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

------

**ITEM 5. OTHER INFORMATION**

During the three months ended September 30, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;3.1 | [<u>Restated Certificate of Incorporation of Forrester Research, Inc. (see Exhibit 3.1 to Registration Statement on Form S-1A filed on November 5, 1996)</u>](https://www.sec.gov/Archives/edgar/data/1023313/0000950135-96-004663.txt) |
| &nbsp;&nbsp;&nbsp;&nbsp;3.2 | [<u>Certificate of Amendment of the Certificate of Incorporation of Forrester Research, Inc. (see Exhibit 3.1 to Annual Report on Form 10-K for the year ended December 31, 1999)</u>](https://www.sec.gov/Archives/edgar/data/1023313/000095013500001340/0000950135-00-001340.txt) |
| &nbsp;&nbsp;&nbsp;&nbsp;3.3 | [<u>Certificate of Amendment to Restated Certificate of Incorporation of Forrester Research, Inc. (see Exhibit 3.1 to Form 8-K filed on May 25, 2017)</u>](https://www.sec.gov/Archives/edgar/data/1023313/000119312517183027/d402162dex31.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;3.4 | [<u>Amended and Restated By-Laws of Forrester Research, Inc. (see Exhibit 3.4 to Annual Report on Form 10-K for the year ended December 31, 2022)</u>](https://www.sec.gov/Archives/edgar/data/1023313/000095017023007151/forr-ex3_4.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.1 | [<u>Specimen Certificate for shares of Common Stock, $.01 par value, of Forrester Research, Inc. (see Exhibit 4 to Registration Statement on Form S-1A filed on November 5, 1996)</u>](https://www.sec.gov/Archives/edgar/data/1023313/0000950135-96-004663.txt) |
| &nbsp;&nbsp;&nbsp;&nbsp;31.1 | [<u>Certification of the Principal Executive Officer. (filed herewith)</u>](forr-ex31_1.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;31.2 | [<u>Certification of the Principal Financial Officer. (filed herewith)</u>](forr-ex31_2.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;32.1 | [<u>Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (furnished herewith)</u>](forr-ex32_1.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;32.2 | [<u>Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (furnished herewith)</u>](forr-ex32_2.htm) |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (filed herewith) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document With Embedded Linkbase Documents. (filed herewith) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document). (filed herewith) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| FORRESTER RESEARCH, INC. | FORRESTER RESEARCH, INC. |
| By: | /s/ L. CHRISTIAN FINN |
|  | L. Christian Finn |
|  | Chief Financial Officer <br>(Principal financial officer) |

---

Date: November 10, 2025

------

## Exhibit 31.1

**Exhibit 31.1**

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

I, George F. Colony, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Forrester Research, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ GEORGE F. COLONY |
| George F. Colony |
| Chairman of the Board and Chief Executive Officer |
| (Principal executive officer) |

---

Date: November 10, 2025

------

## Exhibit 31.2

**Exhibit 31.2**

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

I, L. Christian Finn, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Forrester Research, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ L. CHRISTIAN FINN |
| L. Christian Finn |
| Chief Financial Officer  |
| (Principal financial officer) |

---

Date: November 10, 2025

------

## Exhibit 32.1

**Exhibit 32.1**

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of Forrester Research, Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1) the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, as filed with the Securities and Exchange Commission (the "10-Q Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the 10-Q Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ George F. Colony |
| George F. Colony |
| Chairman of the Board and Chief Executive Officer |

---

Dated: November 10, 2025

------

## Exhibit 32.2

**Exhibit 32.2**

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of Forrester Research, Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1) the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, as filed with the Securities and Exchange Commission (the "10-Q Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the 10-Q Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ L. CHRISTIAN FINN |
| L. Christian Finn |
| Chief Financial Officer |

---

Dated: November 10, 2025

------